06:14 AM EDT, 09/24/2026 (MT Newswires) -- Bernstein lifted its price target for Sonova (SOON.SW), as analysts noted that improving hearing aid market conditions and ongoing wholesale momentum are driving their above-consensus earnings expectations. "Sonova is our top short-term pick as the company is well positioned into its H1 2026/27E results (Nov 2026), supported by continued strength in its Wholesale business. Multiple drivers should underpin further market share gains and above-market growth through FY26/27, including improving underlying market conditions, the EON Sphere launch, continued momentum at Costco, and a further seven months of the Virto R VA tailwind. Margins should benefit from operational leverage and the recent weakening of the Swiss Franc," according to a note focused on European consumer medical technology companies published Wednesday. Bernstein models fiscal first-half wholesale organic growth of 10.1% and group organic growth of 6.5%, beating market forecasts of 8% and 4.9%, respectively. Analysts also anticipate a "sharp" fiscal second-half business improvement for cochlear implants, alongside accelerating retail mergers and acquisitions contribution as main rivals grapple with financial constraints. As such, the research firm raised the outperform-rated stock's price target to 275 francs from 255 francs.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.